Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (12): 759-761.
DOI: 10.19803/j.1672-8629.2019.12.11
Previous Articles Next Articles
HONG Qian
Received:2019-12-18
Revised:2019-12-18
Online:2019-12-15
Published:2019-12-18
CLC Number:
HONG Qian. One Case of Anaphylactic Shock with Hemolytic Anemia Induced by Cedodizime Sodium for Injection[J]. Chinese Journal of Pharmacovigilance, 2019, 16(12): 759-761.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgywjj.com/EN/10.19803/j.1672-8629.2019.12.11
| [1] 刘太雨,田春华. 注射用头孢曲松钠临床使用中常见问题刍议[J]. 中国药物警戒, 2013, 10(8):497-500. [2] 巫建群. 165例药源性过敏性休克文献分析[J]. 北方药学, 2019, 16(3):192-194. [3] 王滨,边瑞民,魏传梅,等.头孢地嗪增加老年细菌性肺炎患者外周血 CD4/CD8 和 Th1/Th2 细胞比例[J]. 细胞与分子免疫学杂志, 2015, 31(4): 528-531. [4] 杨阳,王洁,丁红梓,等. 头孢地嗪致不良反应的文献分析[J].现代药物与临床, 2018, 33(6): 1537-1541. [5] 尚红,王兰兰. 实验诊断学(第3版)[M]. 北京: 人民卫生出版社, 2015:54, 179, 299. [6] Garratty G.Review:drug-induced immune hemolytic anemia--the last decade[J]. Immunohematology, 2004,20(3):138-146. [7] Kleinman M E, Goldberger Z D, Rea T, et al.2017 American Heart Association Focused Update on Adult Basic Life Support and Cardiopulmonary Resuscitation Quality: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care[M]. Circulation, 2018,137(1): e7-e13. [8] Arndt P A.Drug-induced immune hemolytic anemia:the last 30 years of changes[J]. Immunohematol, 2014,30(2) :44-54. [9] 姚晓英,孟现民. 121例皮试阴性后使用头孢类注射剂致过敏性休克的文献分析[J].中国药物警戒, 2015,12(6):352-356. [10] 国家药品不良反应监测中心. 药品不良反应信息通报—警惕注射用头孢硫脒引起的过敏性休克及儿童用药风险. 中国药物警戒, 2016,13(5):316. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
